lupis

French Biotech Firm NeoVacs Goes Public

French biotech company Neovacs said March 19 that it will attempt to raise €20 million ($27.3 million) on the Alternext Exchange of NYSE Euronext in Paris. The developer will offer 3.9 million new shares from a capital increase or 27.46 percent of its capital, and will price the shares between €5.2 and €6.0 per share.Read more

Syndicate content